Medreich Limited Sulfamethoxazole Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Sulfamethoxazole Export Records India — #9 Exporter, 20 Shipments, $454.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sulfamethoxazole

India Pharmaceutical Trade Intelligence

$19.8M145 Suppliers92 CountriesHS 30042020

ExportsIndia → ZIMBABWE20.0%India → UNITED STATES18.9%

ImportsGERMANY → India$74.8K UNITED KINGDOM → India$1.6K

#1 Supplier: MICRO LABS #1 Buyer: MINISTRY OF

Medreich Limited — Sulfamethoxazole Exporter #9 | $454.4K Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Sulfamethoxazole Exporter Profile

Indian Pharmaceutical Exporter · #9 for Sulfamethoxazole · $454.4K export value · DGFT Verified

Medreich Limited is the #9 Indian exporter of Sulfamethoxazole with $454.4K in export value and 20 verified shipments. Medreich Limited holds a 2.3% market share in Sulfamethoxazole exports across 1 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Sulfamethoxazole Export Profile: Buyers & Destinations

Medreich Limited Sulfamethoxazole export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Sulfamethoxazole?

Country	Value	Shipments	Share
UNITED STATES	$3.7M	76	34.1%
ZIMBABWE	$1.4M	28	12.8%
TANZANIA	$734.0K	18	6.7%
SUDAN	$671.9K	24

Who Are the Top Buyers of Sulfamethoxazole from India?

Buyer	Country	Value	Orders
MINISTRY OF HEALTH AND CHILD CARE	ZIMBABWE	$1.8M	36
PROGRAMME DES NATIONS UNIES	TANZANIA	$750.0K	15
UNDP SOUTH SUDAN	SOUTH SUDAN	$636.3K	16
RX CROSSROADS 3PL LLC	UNITED STATES	$636.0K	23
LABORATOIRE BAILLY CREAT	FRANCE	$454.4K	20
XXROBXXDO XXARMXXUSAXXNC	UNITED STATES	$427.3K	11
CAMEG	BURKINA FASO	$400.0K	8
AMNEAL PHARMACEUTICALS LLC NJ	UNITED STATES	$250.0K	5
PROGRAMME DES NATIONS UNIES POUR LE	CONGO	$250.0K	5
XXONUXXPHAXXA LXX	UNITED STATES	$200.0K	4

India's Sulfamethoxazole is purchased by 266 buyers worldwide. The top buyer is MINISTRY OF HEALTH AND CHILD CARE (ZIMBABWE), followed by PROGRAMME DES NATIONS UNIES and UNDP SOUTH SUDAN.

How Does Medreich Limited Compare to Nearest Sulfamethoxazole Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	SOMERSET THERAPEUTICS LIMITED	$616.2K	22	1	$28.0K
8	JODAS EXPOIM PRIVATE LIMITED	$481.8K	21	1	$22.9K
9	MEDREICH LIMITED ★	$454.4K	20	1	$22.7K
10	MEDICAMEN BIOTECH LIMITED	$442.8K	18	2	$24.6K
11	CIPLA LIMITED	$404.2K	38	6	$10.6K

Medreich Limited ranks #9 among 145 Indian Sulfamethoxazole exporters. Average shipment value of $22.7K compared to the market average of $84.0K. The closest competitors by value are SOMERSET THERAPEUTICS LIMITED and JODAS EXPOIM PRIVATE LIMITED.

Which Indian Ports Ship Sulfamethoxazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	85	9.7%
JNPT/ NHAVA SHEVA SEA	83	9.5%
SAHAR AIR	72	8.2%
JNPT	65	7.4%
SAHAR AIR CARGO ACC (INBOM4)	62	7.1%
PITHAMPUR ICD	42	4.8%
APIIC PHARMA SEZ	24	2.7%
NHAVA SHEVA	24	2.7%

Geopolitical & Trade Policy Impact on Medreich Limited's Sulfamethoxazole Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sulfamethoxazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 92+ countries, 266+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sulfamethoxazole

Sulfamethoxazole

Medreich Limited — Sulfamethoxazole Exporter Profile

Medreich Limited — Sulfamethoxazole Export Profile: Buyers & Destinations

Where Does India Export Sulfamethoxazole?

Who Are the Top Buyers of Sulfamethoxazole from India?

What Is India's Total Sulfamethoxazole Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Sulfamethoxazole Exports?

How Does Medreich Limited Compare to Other Indian Sulfamethoxazole Exporters?

Regulatory Requirements: Exporting Sulfamethoxazole to Key Markets

United States — FDA

How Does Medreich Limited Compare to Nearest Sulfamethoxazole Exporters?

Which Indian Ports Ship Sulfamethoxazole Exports?

Geopolitical & Trade Policy Impact on Medreich Limited's Sulfamethoxazole Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sulfamethoxazole Export Data from Medreich Limited

Sulfamethoxazole Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source